Steady-State Bioequivalence of Extended-Release Once-Daily Trokendi XR® to Immediate-Release Topiramate (TPM-IR, Topamax®)

被引：0
|
作者：
Roers, E. [1 ]
Brittain, S. T. [1 ]
Baroldi, P. [1 ]
机构：
[1] Supernus Pharmaceut Inc, Rockville, MD USA
来源：
HEADACHE | 2016年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PF46
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [1] Cognitive Tolerability with Once-Daily Trokendi XR® (extended-release topiramate) vs. Immediate-Release Topiramate
    O'Neal, Welton
    Hur, Elizabeth E.
    Liranso, Tesfaye
    Barr, Peri
    Chung, Haechung
    Gu, Tao
    Tunceli, Ozgur
    Turner, Ralph M.
    [J]. CEPHALALGIA, 2017, 37 : 87 - 88
  • [2] Cognitive Effects of Extended-Release Trokendi XR® vs b.i.d. Immediate-Release Topiramate (TPM-IR, Topamax®) in Healthy Volunteers
    Brittain, S. T.
    [J]. HEADACHE, 2016, 56 : 38 - 39
  • [3] Cognitive Tolerability with Once-Daily Trokendi XRVR (extended-release Topiramate) vs. Immediate-Release Topiramate
    O'Neal, W.
    Hur, E.
    Liranso, T.
    Brittain, S.
    Barr, P.
    Chung, H.
    Gu, T.
    Tunceli, O.
    Turner, R.
    [J]. HEADACHE, 2017, 57 : 180 - 181
  • [4] Effect on Verbal (Phonemic) Fluency and Patient Satisfaction in Chronic Migraine Patients Converted from Immediate-Release Topiramate (TPM-IR) to Extended-Release Topiramate (Trokendi XR®)
    Rothrock, John
    Michael, Amanda
    Andress-Rothrock, Diane
    [J]. NEUROLOGY, 2017, 88
  • [5] Relationship Between Utilization of Triptans and Topiramate Prescribed as Immediate-release Topiramate (TPM-IR) or Trokendi XR in State Medicaid Programs
    Busse, G. D.
    O'Neal, W.
    [J]. HEADACHE, 2018, 58 (08): : 1318 - 1318
  • [6] Effect on Verbal (Phonemic) Fluency and Patient Satisfaction in Chronic Migraine Patients Converted from Immediate-Release Topiramate (TPM-IR) to Extended-Release Topiramate (Trokendi XR®)
    Rothrock, J. F.
    Michael, A.
    Andress-Rothrock, D.
    [J]. HEADACHE, 2017, 57 : 196 - 196
  • [7] Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation
    Bialer, Meir
    Shekh-Ahmad, Tawfeeq
    Braun, Tricia L.
    Halvorsen, Mark B.
    [J]. EPILEPSIA, 2013, 54 (08) : 1444 - 1452
  • [8] Cognitive tolerability and health outcomes with once-daily Trokendi XR® (extended-release topiramate) in migraineurs
    O'Neal, W.
    Hur, E.
    Liranso, T.
    Brittain, S.
    Barr, P.
    Chung, H.
    Gu, T.
    Tunceli, O.
    Turner, R.
    [J]. JOURNAL OF PAIN, 2017, 18 (04): : S67 - S67
  • [9] Real-world assessment of treatment with extended-release topiramate (Trokendi XR®) and comparison with previous immediate-release topiramate treatment
    O'Neal, Welton
    Hur, Elizabeth E.
    Liranso, Tesfaye
    Patel, Barry
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (11) : 1095 - 1105
  • [10] Retrospective Claims-Based Comparative Health Outcomes Study: Trokendi XR® (extended-release topiramate) vs. Immediate-Release Topiramate
    O'Neal, W.
    Hur, E. E.
    Liranso, T.
    Turner, R. M.
    [J]. HEADACHE, 2016, 56 : 43 - 43
12345